Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 17;14(8):806.
doi: 10.3390/ph14080806.

Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus

Affiliations
Review

Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus

Jana Blahova et al. Pharmaceuticals (Basel). .

Abstract

Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium-glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided.

Keywords: combination therapy; molecular mechanisms; natural therapeutic products; pharmaceutical drugs; treatment; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Selected secondary complications associated with T2DM.
Figure 2
Figure 2
The mechanism of insulin release by pancreatic β-cells. ER: endoplasmic reticulum, GA: Golgi apparatus, ATP: adenosine triphosphate, Ca2+: calcium ion.
Figure 3
Figure 3
Chemical structures of selected natural compounds.

Similar articles

Cited by

References

    1. Milibari A.A., Matuure E.Y., Gadah E.M. Prevalence, Determinants and Prevention of Type 2 Diabetes Mellitus (T2DM) in Arabic Countries: A Systematic Review Study. Health Sci. J. 2020;14:1–8. doi: 10.36648/1791-809X.14.2.701. - DOI
    1. Olokoba A.B., Obateru O.A., Olokoba L.B. Type 2 Diabetes Mellitus: A Review of Current Trends. Oman Med. J. 2012;27:269–273. doi: 10.5001/omj.2012.68. - DOI - PMC - PubMed
    1. Wu Y., Ding Y., Tanaka Y., Zhang W. Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention. Int. J. Med. Sci. 2014;11:1185–1200. doi: 10.7150/ijms.10001. - DOI - PMC - PubMed
    1. Sesti G., Federici M., Lauro D., Sbraccia P., Lauro R. Molecular Mechanism of Insulin Resistance in Type 2 Diabetes Mellitus: Role of the Insulin Receptor Variant Forms. Diabetes Metab. Res. Rev. 2001;17:363–373. doi: 10.1002/dmrr.225. - DOI - PubMed
    1. Deshmukh C., Jain A., Nahata B. Diabetes Mellitus: A Review. Int. J. Pure Appl. Biosci. 2015;3:224–230.

LinkOut - more resources